Hypothalamic-pituitary corticotroph function after shunting of magnocellular vasopressin and oxytocin to the hypophyseal portal circulation

Endocrinology

Volumn 137, Issue 2, 1996, Pages 580-586

  Makara, Gabor B ^b   Kiss, Alexander ^d   Lolait, Stephen J ^a   Aguilera, Greti ^c  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c Developmental Endocrinology Branch   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTERONE; CORTICOTROPIN; DESMOPRESSIN; OXYTOCIN; VASOPRESSIN; VASOPRESSIN RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CORTICOTROPIN BLOOD LEVEL; DIABETES INSIPIDUS; HYPOPHYSIS FUNCTION; HYPOTHALAMUS FUNCTION; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMMUNOCYTOCHEMISTRY; INFUNDIBULUM; MAGNOCELLULAR NUCLEUS; MALE; MEDIAN EMINENCE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION; RECEPTOR OCCUPANCY; THALAMUS MIDLINE NUCLEUS;

EID: 0030024262     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.137.2.8593805     Document Type: Article

References (37)

1. Antoni FA 1986 Hypothalamic control of adrenocorticotropin secretion: advances since the discovery of 41-residue corticotropin releasing factor. Endocr Rev 7:351-378
2. Aguilera G 1994 regulation of pituitary ACTH secretion during chronic stress. Front Neuroendocrinol 15:321-350
3. Jard S, Gaillard RC, Guillon G, Marie JN, Shoenenberg P, Muller AF, Manning M, Sawyer WH 1986 Vasopressin antagonists allow demonstration of a novel type of vasopressin receptor in the rat adenohypophysis. Mol Pharmacol 30:171-177
4. Antoni FA, Holmes MC, Makara GB, Karteszi M, Laszlo FA 1984 Evidence that the effects of arginine-8-vasopressin (AVP) on pituitary corticotropin (ACTH) release are mediated by a novel type of receptor. Peptides 5:519-522
5. Sumimoto T, Saito M, Mochizuki S, Wanatabe Y, Hashimoto S, Kawashima H 1994 Molecular cloning and functional expression of a cDNA encoding the human V1b vasopressin receptor. J Biol Chem 269:27088-27092
6. Lolait SJ, O'Carroll AM, Mahan LC, Felder CC, Button OC, Young III WS, Mezey E, Brownstein MJ 1995 Extrapituitary expression of the rat V1b vasopressin receptor gene. Proc Natl Acad Sci USA 92:6783-6787
7. Whitnall M, Mezey E, Gainer H 1985 Colocalization of corticotropin releasing factor, vasopressin in median eminence secretory vesicles. Nature 317:248-250
8. DeGoeij DCE, Binnekade R, Tilders FJH 1992 Chronic stress enhances vasopressin but not corticotropin releasing factor secretion during hypoglycemia. Am J Physiol 26:E394-E399
9. Bartanusz V, Jezova D, Bertini LT, Tilders FJ, Aubry JM, Kiss JZ 1993 Stress induced increase in vasopressin and corticotropin releasing factor expression in hypophysiotropic paraventricular neurons. Endocrinology 132:895-902
10. Priou A, Oliver C, Grino M 1993 In situ hybridization of arginine vasopressin (AVP) heteronuclear ribonucleic acid reveals increased AVP gene transcription in the rat hypothalamic paraventricular nucleus in response to emotional stress. Acta Endocrinol (Copenh) 128:466-472
11. Aguilera G, Pham Q, Rabadan-Diehl C 1994 Regulation of pituitary vasopressin receptors during chronic stress: relationship to corticotroph responsiveness. J Neuroendocrinol 6:299-304
12. Rittmaster RS, Cutler GB, Gold PW, Brandon DD, Tomai T, Loriaux DL, Chrousos GP 1987 The relationship of saline induced changes in vasopressin secretion to basal and corticotropin releasing hormone-stimulated adrenocorticotropin and cortisol secretion in man. J Clin Endocrinol Metab 64:371-376
13. Raff H, Papanek PE, Cowley AW 1992 Effect of hypotension and hyperosmolarity on vasopressin and ACTH responses to hypoglycemia in conscious dogs. Am J Physiol 263:R382-R388
14. Irvine CHG, Alexander SL, Donald RA 1989 Effects of an osmotic stimulus on the secretion of arginine vasopressin and adrenocorticotropin in the horse. Endocrinology 124:3102-3108
15. Dohanics J, Kovacs KJ, Folly G, Makara GB 1990 Long term salt loading impairs pituitary responsiveness to ACTH secretagogues and stress in rats. Peptides 11:59-63
16. Chowdry HS, Jessop DS, Lightman SL 1991 Altered adrenocorticotropin, corticosterone and oxytocin responses to stress during chronic salt load. Neuroendocrinology 54:635-638
17. Aguilera G, Lightman SL, Kiss A 1993 Regulation of the hypothalamic-pituitary-adrenal axis during water deprivation. Endocrinology 132:241-248
18. Kock B, Lutz-Bucher B 1985 Specific receptors for vasopressin in the pituitary gland: evidence for downregulation and desensitization to adrenocorticotropin releasing factors. Endocrinology 116:671-676
19. Tizabi Y, Aguilera G 1993 Desensitization of the hypothalamic-pituitary-adrenal axis following prolonged administration of corticotropin releasing hormone or vasopressin. Neuroendocrinology 56:611-618
20. Dohanics J, Hoffman GE, Smith SM, Verbalis JG 1992 Functional neurolobectomy induced by controlled compression of the pituitary stalk. Brain Res 575:215-222
21. Makara GB 1993 Denervation of the rat posterior pituitary gland: validation of a stereotaxic method. J Neuroendocrinol 5:335-340
22. Makara GB, Sutton S, Otto S, Plotsky P 1995 Marked changes of arginine vasopressin, oxytocin and corticotropin releasing hormone in hypophyseal portal plasma after pituitary stalk damage in the rat. Endocrinology 136:1864-1868
23. Berod A, Hartman BK, Pujol JF 1981 Importance of fixation in immunohistochemistry: use of formaldehyde solutions at variable pH for the localization of tyrosine hydroxylase. J Histochem Cytochem 29:844-850
24. Wynn PC, Hauger RL, Holmes MC, Millan MA, Catt KJ, Aguilera G 1984 Brain and pituitary receptors for corticotropin releasing factor: differential regulation after adrenalectomy. Peptides 5:1077-1084
25. Harbuz MS, Lightman SL 1989 Responses of hypothalamic and pituitary mRNA to physical and psychological stress in the rat. J Endocrinol 122:705-711
26. Luo X, Kiss A, Makara GB, Lolait SJ, Aguilera G 1994 Stress specific regulation of corticotropin releasing hormone receptor expression in the paraventricular and supraoptic nuclei of the hypothalamus in the rat. J Neuroendocrinol 6:689-696
27. Sawchenko PE, Imaki T, Potter E, Kovaks K, Imaki I, Vale WW 1993 The functional anatomy of corticotropin releasing factor. In: Chadwick DJ, Marsh J, Akrill K (eds) Corticotropin Releasing Factor. Ciba Foundation Symp 172, Wiley and Sons, New York, pp 5-26
28. Levin N, Roberts JL 1991 Positive regulation of proopiomelanocortin gene expression in corticotropes and melanotropes. Front Neuroendocrinol 12:1-22
29. Davis D 1986 The hypothalamo-hypophyseal rat expiant in vitro: endocrinological studies of the pars intermedia dopaminergic input. J Physiol 370:381-393
30. Loeffler JP, Demeneix BA, Pittius CW, Kley N, Haegele KD, Hilt V 1986 GABA differentially regulates gene expression of proopiomelanocortin in rat intermediate and anterior pituitary. Peptides 7:253-258
31. Seger MA, Kiss JZ, van Tol HHM, Burbach JPH 1987 Biosynthesis of proopiomelanocortin is increased in the rat intermediate pituitary following denervation. Neurosci lett 83:149-155
32. Herman JP, Marciano FF, Wiegand SJ, Gash DM 1987 Selective cell death of magnocellular vasopressin neurons in neuro-hypophysectomized rats following chronic administration of vasopressin. J Neurosci 7:2564-2575
33. Fagin KD, Wiener SG, Dallman MF, 1985 ACTH and corticosterone secretion in rats following removal of the neurointermediate lobe of the piruitary gland. Neuroendocrinology 40:352-362
34. Young WS 1986 Corticotropin releasing factor mRNA in the hypothalamus is affected differently by drinking saline or by dehydration. FEBS Lett 208:158-161
35. Plotsky PM, Bruhn TO, Vale W 1984 Central modulation of immunoreactive corticotropin-releasing factor secretion by arginine vasopressin. Endocrinology 115:1639-1641
36. Makara GB, Kiss A, Luo X, Lolait SJ, Aguilera G Decreased hypothalamic corticotropin releasing hormone mRNA following surgical shunting of magnocellular vasopressin to the pituitary portal circulation. Program of the 77th Annual Meeting of The Endocrine Society, Washington DC, 1995, p 254 (Abstract PI-567)
37. Palkovits M 1986 Afferents onto neuroendocrine cells. In: Ganten D, Pfaff D (eds) Current Topics in Neuroendocrinology. Springer-Verlag, Berlin, pp 197-222